首页> Journal of gastroenterology and hepatology> All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy.

All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ian,Lockart

第一单位： St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.;St Vincent's Hospital, Sydney, New South Wales, Australia.

作者： Ian,Lockart ^[1] ; Behzad,Hajarizadeh ^[2] ; Niamh,Buckley ^[3] ; Scott,Davison ^[4] ; Emilia,Prakoso ^[5] ; Miriam T,Levy ^[4] ; Jacob,George ^[6] ; Gregory J,Dore ^[7] ; Mark,Danta ^[1]

作者单位： St Vincent's Clinical School, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.;St Vincent's Hospital, Sydney, New South Wales, Australia. ^[1] The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia. ^[2] St Vincent's Hospital, Sydney, New South Wales, Australia. ^[3] Liverpool Hospital, Sydney, New South Wales, Australia.;South Western Clinical School, University of New South Wales, Sydney, New South Wales, Australia. ^[4] Liverpool Hospital, Sydney, New South Wales, Australia.;Central Clinical School, The Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia. ^[5] Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Westmead Hospital, Sydney, New South Wales, Australia. ^[6] St Vincent's Hospital, Sydney, New South Wales, Australia.;The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia. ^[7]

关键词 hepatitis C hepatocellular carcinoma survival analysis

医学主题词抗病毒药(Antiviral Agents);癌, 肝细胞(Carcinoma, Hepatocellular);丙型肝炎, 慢性(Hepatitis C, Chronic);人类(Humans);肝肿瘤(Liver Neoplasms);回顾性研究(Retrospective Studies);存活率分析(Survival Analysis)

DOI 10.1111/jgh.15687

PMID 34520088

发布时间 2022-03-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交